Cibotti R, Cabaniols J P, Pannetier C, Delarbre C, Vergnon I, Kanellopoulos J M, Kourilsky P
U.277 Institut National de la Santé et de la Recherche Médicale (INSERM), Immunology Department, Institut Pasteur, Paris, France.
J Exp Med. 1994 Sep 1;180(3):861-72. doi: 10.1084/jem.180.3.861.
We have previously produced a transgenic mouse line for hen egg lysozyme (HEL), an experimental model for analyzing tolerance to self-antigens at the peptide level. We have now characterized transgenic mice with HEL blood levels below 2 ng/ml, where significant T cell proliferative responses to HEL and its immunodominant peptide were observed. This HEL-low transgenic model was chosen because it mimics physiological conditions in which autoreactive T lymphocytes, recognizing self-components expressed at very low levels, persist without inducing a break in tolerance. Furthermore, in H-2d mice, HEL-specific T lymphocytes are triggered by a single immunodominant region, allowing us to compare the HEL-specific T cell V beta repertoires of transgenic and nontransgenic animals against a single peptide presented as self or foreign, respectively. We found that a V beta 8.2-D beta 1-J beta 1.5 rearrangement is found in response to HEL in all nontransgenic mice, whereas this V beta-restricted response is absent in HEL-low transgenic animals. At the nucleotide level, this rearrangement results from the trimming of the genomic segments during VDJ or DJ joining, without N additions, suggesting that the dominant rearrangement is selected early during fetal or neonatal life, before the expression of terminal deoxynucleotidyl transferase. In HEL-low transgenic mice, no dominant rearrangements are found as alternatives to the one observed in normal mice. Instead, each transgenic animal uses a different set of V beta-J beta combinations in its response to the immunodominant HEL peptide. In nontransgenic mice, besides the dominant V beta 8.2-D beta 1-J beta 1.5 combination, minor V beta repertoires were found which differed in each animal and were distinct from the rearrangements used by individual transgenic mice. These findings suggest that the T cell response to an immunodominant peptide involves a "public" V beta repertoire found in all animals and a "private" one which is specific to each individual.
我们之前培育了一种用于鸡卵溶菌酶(HEL)的转基因小鼠品系,这是一种在肽水平分析对自身抗原耐受性的实验模型。我们现在对血液中HEL水平低于2 ng/ml的转基因小鼠进行了特征分析,在这些小鼠中观察到了对HEL及其免疫显性肽的显著T细胞增殖反应。选择这个HEL低表达转基因模型是因为它模拟了生理条件,即识别极低水平表达的自身成分的自身反应性T淋巴细胞持续存在而不导致耐受性破坏。此外,在H-2d小鼠中,HEL特异性T淋巴细胞由单个免疫显性区域触发,这使我们能够分别比较转基因和非转基因动物针对作为自身或外来呈现的单个肽的HEL特异性T细胞Vβ谱系。我们发现,在所有非转基因小鼠中,针对HEL会出现Vβ8.2-Dβ1-Jβ1.5重排,而在HEL低表达转基因动物中不存在这种Vβ限制的反应。在核苷酸水平上,这种重排是在VDJ或DJ连接过程中基因组片段修剪的结果,没有添加N,这表明优势重排在胎儿或新生儿期早期,即在末端脱氧核苷酸转移酶表达之前就被选择了。在HEL低表达转基因小鼠中,没有发现作为正常小鼠中观察到的重排替代的优势重排。相反,每只转基因动物在对免疫显性HEL肽的反应中使用不同的Vβ-Jβ组合。在非转基因小鼠中,除了优势Vβ8.2-Dβ1-Jβ1.5组合外,还发现了次要的Vβ谱系,每只动物的次要Vβ谱系都不同,并且与单个转基因小鼠使用的重排不同。这些发现表明,T细胞对免疫显性肽的反应涉及所有动物中都存在的“公共”Vβ谱系和每个个体特有的“私有”Vβ谱系。